Metabolic network as a progression biomarker of premanifest Huntington’s disease

Background. The evaluation of effective disease-modifying therapies for neurodegenerative disorders relies on objective and accurate measures of progression in at-risk individuals. Here we used a computational approach to identify a functional brain network associated with the progression of preclin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tang, Chris C., Feigin, Andrew, Ma, Yilong, Habeck, Christian, Paulsen, Jane S., Leenders, Klaus L., Teune, Laura K., van Oostrom, Joost C.H., Guttman, Mark, Dhawan, Vijay, Eidelberg, David
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2013
Assuntos:
Clinical Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3754266/
https://ncbi.nlm.nih.gov/pubmed/23985564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI69411
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados